Public Health England
Dr Jenny Harries marks official launch of UK Health Security Agency
New chief executive marked her first day with a visit to Colindale laboratories in North London, accompanied by Health Secretary Matt Hancock.
Dr Jenny Harries marked her first day as chief executive of the new UK Health Security Agency (UKHSA) with a visit to Colindale laboratories in North London, accompanied by Health and Social Care Secretary Matt Hancock.
The visit, timed to mark the formal establishment of the UKHSA, focused on the work being done to help the UK understand and respond to new variants of the virus causing COVID-19, and the extensive expertise being deployed to monitor the roll-out of the vaccine programme as well as the ongoing monitoring and surveillance of the infection.
Dr Harries and the Health and Social Care Secretary spoke to the team involved in developing the original test for COVID-19, which began work as soon as reports first emerged from China.
They visited scientists working across vital elements of the pandemic response, including vaccines and serology studies to better understand how many people in the population have antibodies against coronavirus.
They also spoke to the team in the national sequencing service, where whole genome sequencing for COVID-19 takes place in order to detect new variants.
Dr Harries used the visit to highlight her ambition to boost public recognition for the vast amount of work that goes into protecting people’s health.
Dr Jenny Harries, Chief Executive, UKHSA recently said:
It is a significant moment as the work of the UK Health Security Agency begins with a specific focus on pandemics and public health threats. We have learned so much from responding to COVID-19 and this is a brilliant opportunity to ensure these lessons can be applied in the future, with the scale and capacity needed to save lives and protect the public.
Health protection needs to be noisy, be visible, so people are aware of how much work is happening to protect communities.
There is work to do right away as we continue our fight against COVID-19, even with the success of our vaccine programme so far, and the tentative steps we have made on the roadmap to return to normality. The UKHSA will work with our regional, national and global partners to tackle this virus while ensuring we are ready to face future health challenges.
The new agency will work to protect the country from future health threats and ensure the nation can respond to pandemics quickly and at greater scale.
The laboratories at Colindale, which have been operating throughout the pandemic under Public Health England leadership, will transfer to the new UKHSA.
Health and Social Care Secretary Matt Hancock recently said:
This is an important day as we launch the UK Health Security Agency to ensure that we protect the public and prepare for the next pandemic. The team working at UKHSA, expertly led by Dr Jenny Harries, will spend every day focused on the current and future health threats facing our country so we are always ready for whatever is on the horizon.
The primary focus for the UKHSA in its initial phase of operation will be the continued fight against the COVID-19 pandemic.
It will bring together the country’s cutting-edge health security science capabilities, data analytics and genomic surveillance with at scale testing and contact tracing capability – combining key elements of Public Health England with NHS Test and Trace including the Joint Biosecurity Centre.
Formally established in April 2021, the UKHSA will be chaired by Ian Peters, currently Chair of Barts Health NHS Trust and former Chief Executive of British Gas, Managing Director of NatWest Small Business Services, and chairman of several data driven growth technology companies.
Latest News from
Public Health England
COVID-19 vaccines have prevented 10,400 deaths in older adults12/04/2021 10:10:10
PHE analysis suggests the UK COVID-19 vaccination programme has so far prevented thousands of deaths in those aged 60 and above.
New JCVI advice on use of the AstraZeneca COVID-19 vaccine08/04/2021 14:05:00
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
New vaccine advice for adults living with adults who are immunosuppressed30/03/2021 09:05:00
JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine.
COVID-19 vaccines have prevented thousands of deaths in older adults, new data shows26/03/2021 09:33:00
Analysis carried out by Public Health England suggests that the COVID-19 vaccination programme prevented 6,100 deaths in England up to the end of February 2021.
PHE study shows three-quarters of over 70s have COVID-19 antibodies18/03/2021 16:38:00
New findings from Public Health England have shown that an estimated 75.8% of 70 to 84 year old blood donors had antibodies against COVID-19 by early March.
JCVI advises prioritising homeless people and rough sleepers for COVID-19 vaccine12/03/2021 16:10:00
The JCVI has advised the government to prioritise people experiencing homelessness, including those sleeping rough, for the coronavirus (COVID-19) vaccine.
Relaunch of the Act FAST campaign to improve stroke outcomes09/03/2021 14:20:00
New data suggests that people put off seeking help for stroke during pandemic.
Schools and colleges reopened yesterday as part of Step One of the roadmap09/03/2021 10:10:10
Step One of the roadmap began yesterday with pupils returning to face-to-face education.